Stay updated on INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies
Sign up to get notified when there's something new on the INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies page.

Latest updates to the INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies page
- Check4 days agoChange DetectedAn NIH banner about terminology changes appears above the existing 403 error page, and the site revision label changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe footer’s site revision indicator was updated from v3.7.0 to v3.7.1. The study record remains unavailable behind a 403 error.SummaryDifference0.2%

- Check32 days agoChange DetectedThe page now displays a 403 Forbidden error page, replacing the usual study details. A simple header with 403 and a Home button is shown, indicating that access to the content is blocked.SummaryDifference22%

- Check39 days agoChange DetectedA new page revision tag (Revision: v3.7.0) and accompanying date stamps were added, and the 'Find contact information' label was changed from 'Find Contact Information' to 'Find contact information'. These are cosmetic metadata and UI text changes that do not alter study content, eligibility criteria, or data presented on the page.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing Revision: v3.6.5, signaling a small page update or QA refresh rather than a substantive change to study data.SummaryDifference0.0%

- Check60 days agoChange DetectedA new identifier, '2023 ( U.S. NIH Grant/Contract )', was added under the study's Other Study ID Numbers to reflect NIH funding/identification associated with the trial.SummaryDifference0.0%

Stay in the know with updates to INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies
Enter your email address, and we'll notify you when there's something new on the INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies page.